Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study

Seock-Ah Im,Hirofumi Mukai,In Hae Park,Norikazu Masuda,Chikako Shimizu,Sung-Bae Kim,Young-Hyuck Im,Shoichiro Ohtani,Cynthia Huang Bartlett,Dongrui R. Lu,Shrividya Iyer,Yuko Mori,A. Mori,Eric Gauthier,Richard S. Finn,Masakazu Toi

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study

2019

Seock-Ah Im
Hirofumi Mukai
In Hae Park
Norikazu Masuda
Chikako Shimizu
Sung-Bae Kim
Young-Hyuck Im
Shoichiro Ohtani
Cynthia Huang Bartlett
Dongrui R. Lu
Shrividya Iyer
Yuko Mori
A. Mori
Eric Gauthier
Richard S. Finn
Masakazu Toi

PURPOSEIn PALOMA-2, palbociclib plus letrozole significantly improved progression-free survival (PFS) as initial treatment of estrogen receptor–positive/human epidermal growth factor receptor 2–neg...

Keywords:

Palbociclib
Human epidermal growth factor
Estrogen receptor
Letrozole
Internal medicine
Oncology
Metastatic breast cancer
Receptor
Medicine
initial treatment
human epidermal growth factor receptor
first line therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations